2017 Alzheimer’s Association® Grant Awards
—Organized by Research Categories

Molecular Pathogenesis and Pathophysiology of Alzheimer’s Disease

Discovery of novel mechanisms by which sleep modulates Aß toxicity
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Are there genes that mediate the relationships between sleep and beta-amyloid formation in the brain?

The role of microglial CD33 on amyloid deposition and synaptic pathology
2017 Alzheimer's Association Research Fellowship to Promote Diversity (AARF-D) - $175,000 over 3 years
How might an immune system gene in the brain promote the development of beta-amyloid plaques in Alzheimer’s disease?

Determining the influence of tau pathology on decision making
2017 Alzheimer's Association Research Fellowship (AARF) - $174,973 over 3 years
How are changes in specific markers of brain injury in Alzheimer's disease related to the ability to make financial decisions?

Microglial Fatty Acid Signaling in Alzheimer’s Disease
2017 Alzheimer’s Association Research Grant to Promote Diversity (AARG-D) - $150,000 over 3 years
How does a high-fat diet contribute to brain inflammation and the risk for developing Alzheimer’s disease?

Molecular Mechanisms of Cognitive Decline in Alzheimer’s Disease
2017 Alzheimer’s Association Research Grant (AARG) - $149,997 over 3 years
Do alterations in the protein NR4a2 promote memory loss in Alzheimer’s disease?

Gut Microbiota and host epigenome Interplay in Alzheimer's Disease
2017 Alzheimer's Association Research Grant (AARG) - $120,000 over 2 years
1

Can bacteria in the gut or other fluids alter one’s risk for Alzheimer’s?

Unique neuroimmune signature in Alzheimer’s disease compared to CTE
2017 Alzheimer's Association Research Fellowship (AARF) - $171,920 over 3 years
How does inflammation and tau clumping in the brain differ in Alzheimer's disease and chronic traumatic encephalopathy?

Targeting brain insulin resistance-mediated neuronal dysfunction in AD
2017 Alzheimer's Association Research Fellowship (AARF) - $175,000 over 3 years
How are high levels of insulin in the brain related to the development of Alzheimer's disease?

Role of Glucocorticoid Receptors in Sex-Related Differences in Alzheimer’s Disease
2017 Sex and Gender in Alzheimer’s (SAGA) - $249,999 over 3 years
Are there sex differences in the mechanisms that underlie stress and Alzheimer’s disease?

Neural Mechanisms of Spatial Disorientation in Alzheimer’s disease
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How might damage to “head direction” cells increase one’s risk of Alzheimer’s?

Microglia transplantation in a murine model of Alzheimer's disease
2017 Alzheimer's Association Clinician Scientist Fellowship (AACSF) - $175,000 over 3 years
Can transplanting healthy immune cells into the brain improve Alzheimer’s disease symptoms?

Single-cell RNA-seq in human AD to define selective cell vulnerability
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Why are some nerve cells more vulnerable to dying in Alzheimer’s disease than others?

Role of polyubiquitination in Alzheimer’s disease
2017 Alzheimer's Association Research Grant (AARG) - $133,800 over 3 years
How does modification of tau affect the formation of tau tangles?
2


Microglial modulation of neural activities in models of Alzheimer’s disease
2017 Alzheimer's Association Research Fellowship (AARF) - $175,000 over 3 years
How do microglia in the brain affect the connections between nerve cells in Alzheimer's disease?

"Leaky" ryanodine receptors: Potential role in pathogenesis of AD
2017 Alzheimer's Association Research Fellowship (AARF) - $174,946.92 over 3 years
Why are only certain types of nerve cells in the brain affected in Alzheimer's disease?

Neurobiology of Sex Differences in Memory Capacity in Ageing and Alzheimer’s Disease
2017 Sex and Gender in Alzheimer’s (SAGA) - $249,975 over 3 years
What are the biological factors that may underlie sex differences in memory loss in Alzheimer’s disease?

In vivo Investigation of BIN1 as a Risk Factor in Tau Pathology
2017 Alzheimer’s Association Research Fellowship (AARF) - $173,000 over 3 years
Do certain forms of the BIN1 protein promote the development of tau tangles in Alzheimer’s disease?

Role of N-terminal Residues in Membrane-Mediated Aß Assembly and Toxicity
2017 Alzheimer's Association Research Grant (AARG) - $149,467 over 3 years
How does beta-amyloid clump together and begin causing nerve cell toxicity?

Dissecting the Role of Human Astroglia in Alzheimer’s Disease
2017 Zenith Fellows Award Program - $450,000 over 3 years
How do specialized support cells in the brain called astroglia impact the onset and progression of Alzheimer’s disease?

Role of SUMOylation in the Aggregation and Toxicity of Tau
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
How does a chemical modification called SUMOylation affect the formation of tau tangles in the brain?

3


Targeting Ca2+ dysregulation in Alzheimer’s Disease
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Does the dysregulation of calcium in the brain play a role in the development of Alzheimer's disease?

Identifying Neurons Vulnerable to Tau Pathology in Early Alzheimer’s Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $140,000 over 2 years
Why are some nerve cells particularly vulnerable to tau-related damage in Alzheimer’s disease?

Axonal Transcription Factor Complexes in Alzheimer’s Disease
2017 Alzheimer's Association Research Fellowship (AARF) - $174,999 over 3 years
What factors are involved in the spread of Alzheimer’s in the brain?

Plasticity of entorhinal-hippocampal network in the aged brain
2017 Alzheimer's Association Research Fellowship (AARF) - $174,970 over 3 years
How does aging affect the ability of the brain to make new connections between nerve cells?

The Role of Pericytes in Alzheimer's Disease and Stroke Comorbidity
2017 Alzheimer's Association Research Fellowship (AARF)
How does damage to blood vessels in the brain contribute to Alzheimer's disease?

In vivo entorhinal-hippocampal synchronization in APP knock-in mice
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How might changes in the brain’s electrical rhythms between areas of the brain promote Alzheimer’s disease?

Generation of a Blood-Brain Barrier from Alzheimer's Disease Patient iPSCs
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
How do changes in the blood-brain barrier contribute to the accumulation of beta-amyloid in Alzheimer’s disease?

Relationship between Cerebral Amyloid Angiopathy and Neurovascular Deficits
4

2017 Alzheimer’s Association Research Fellowship (AARF) - $175,000 over 3 years
How does beta-amyloid accumulation in blood vessels relate to brain changes associated with Alzheimer’s disease?

A role for PLD3 in the autophagy-lysosome pathway and Aß clearance
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How can a “waste disposal” protein in the brain affect the development of beta-amyloid plaques in Alzheimer’s disease?

Probiotic Effects on Progression of Alzheimer's Disease
2017 Alzheimer's Association Research Fellowship (AARF) - $175,000 over 3 years
Can promoting healthy bacteria in the intestines help prevent or slow Alzheimer's disease?

A Novel Mechanism of Alzheimer’s Disease Signaling Pathway
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How does the protein DAPK1 influence the production of beta-amyloid and the progression of Alzheimer’s disease?

Towards an Animal Model for Late Onset Alzheimer's Disease
2017 Alzheimer's Association Research Fellowship (AARF) - $140,000 over 2 years
Can a fruit fly model of Alzheimer's disease be used to identify novel genes and gene interactions involved in Alzheimer's?

The Role of Neuronal HSPG in the Propagation of Tau
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
Do HSPG proteins contribute to the movement of abnormal tau protein throughout the brain in Alzheimer’s disease?

Novel Methods to Interrogate the Subcellular Machinery of AD Models in TIVO
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Do brain cells important for learning and memory become altered in ways that lead to their premature death in Alzheimer's
disease?

Gender Effects on identified cell population in Alzheimer’s Disease
2017 Alzheimer's Association Research Grant to Promote Diversity (AARG-D) - $150,000 over 3 years
5

Do brain immune cells respond uniquely in females?

Lateral Entorhinal Cortex-CA1 Interactions in Alzheimer’s Disease
2017 Alzheimer’s Association Clinical Fellowship (AACF) - $175,000 over 3 years
Why are specific brain regions involved in memory vulnerable to the toxic effects of beta-amyloid?

Modelling inflammation in the context of AD using 3D microenvironments
2017 Alzheimer's Association Research Grant to Promote Diversity (AARG-D) - $150,000 over 3 years
How do amyloid plaques form in the brain?

Protective vascular factors in mild cognitive impairment
2017 Alzheimer’s Association Research Grant (AARG) - $149,422 over 3 years
Do circulating stem cells in the blood reduce cognitive decline in older people?

Monitoring the Onset and Evolution of Neuronal Dysfunctions
2017 Alzheimer’s Association Research Fellowship to Promote Diversity (AARF-D) - $173,000 over 3 years
How do abnormal proteins move between nerve cells in Alzheimer’s disease?

Functional role of genetic variation in cell-specific pathogenesis of AD
2017 Alzheimer's Association Research Fellowship (AARF) - $175,000 over 3 years
Functional Role of Genetic Variation in Cell-Specific Pathogenesis of AD Do variations in certain regions of a person's DNA
enhance one's risk for Alzheimer's disease?

Innate Immune Cells in Healthy Aging and Alzheimer’s Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $169,504.22 over 3 years
How do different types of immune cells contribute to brain changes associated with Alzheimer’s disease?

Defining astrocytic-neuronal transcriptional alterations in memory loss.
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Can specialized brain cells, astrocytes, play a major role in promoting memory loss in dementia?
6


PPARalpha in APP Metabolism
2017 Zenith Fellows Award Program - $449,955 over 3 years
Can novel factors produced in the brain help prevent the formation of toxic beta-amyloid?

Interactions Between Sex, APOE4, and Neuroinflammation in Alzheimer's Disease Pathogenesis
2017 Sex and Gender in Alzheimer’s (SAGA) - $249,879 over 3 years
Do natural variations in the APOE gene impact brain inflammation and risk for Alzheimer’s differently in males and females?

Chronic senescence-associated secretory phenotype in neurodegeneration
2017 Alzheimer's Association Research Fellowship to Promote Diversity (AARF-D) - $175,000 over 3 years
Is Alzheimer’s disease due to the age dependent accumulation of brain cells undergoing cellular senescence?

PS1 FAD mutants affect NMDA-EphB receptor interactions and neuroprotection
2017 Alzheimer's Association Research Fellowship (AARF) - $174,981 over 3 years
How do proteins in the brain interact to protect against damage that leads to Alzheimer's disease?

The Consequences of Activity-Induced DNA Breaks in Alzheimer's Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $175,000 over 3 years
Does DNA damage in nerve cells contribute to brain changes associated with Alzheimer’s disease?

Attenuating Aβ-Driven Hyperexcitability and Tau Spread
2017 Alzheimer’s Association Research Fellowship to Promote Diversity (AARF-D) - $140,000 over 2 years
Does beta-amyloid alter nerve cell activity in a way that promotes the movement of abnormal tau throughout the brain?

RAGE, DIAPH1, Microglia, and Alzheimer’s Disease
2017 Zenith Fellows Award Program - $444,225 over 3 years
How do immune cells from the blood enter and interact with specific brain cells to affect the progression of Alzheimer’s disease?

7


Transcriptomic Changes of Astrocytes in Alzheimer's Disease
2017 Alzheimer’s Association Clinical Fellowship (AACF) - $175,000 over 3 years
How do support cells in the brain called astrocytes impact nerve cell function in Alzheimer’s disease?

Roles of DCTN6 in Tubular ER Clustering and DNs Formation in Alzheimer’s Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $175,000 over 3 years
Do low levels of the protein DCTN6 contribute to brain changes associated with Alzheimer’s disease?

A genomic screen to identify endogenous regulators of APP/BACE interaction
2017 Alzheimer's Association Research Fellowship (AARF) - $173,174 over 3 years
What genetic elements regulate the formation of Beta-amyloid?

Neuroinflammatory Susceptibility to Vascular Disease as a Dementia Driver
2017 Alzheimer’s Association Research Grant (AARG) - $149,985 over 3 years
Do variations in genes related to inflammation affect how the brain responds to blood vessel damage?

Brain Sexual Dimorphism and Aging Interact in Development of Alzheimer’s Disease
2017 Sex and Gender in Alzheimer’s (SAGA) - $249,990 over 3 years
Do inherent sex differences in brain structure and hormonal changes during aging interact to affect the development of
Alzheimer’s?

Oligomeric Tau-Induced Microvascular Dysfunction in Alzheimer’s Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $140,000 over 2 years
Does abnormal tau protein disrupt the function of blood vessels in the brain in Alzheimer’s disease?

Seeding Disease: How Pathological Tau Meets Endogenous Tau
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
How does abnormal tau move between nerve cells in Alzheimer’s disease?

8


In vivo Analysis of Cell-Type-Specific Expression of Tau and Tau Spreading
2017 Zenith Fellows Award Program - $450,000 over 3 years
What types of cells are involved in the formation and spread of abnormal tau protein in the brain during Alzheimer’s disease?

Pathomechanisms of TDP-43 in Alzheimer’s Disease
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
Does abnormal accumulation of the protein TDP-43 contribute to nerve cell loss in Alzheimer’s disease?

Genetic Variation in Sirtuins and Associations with Memory & Brain Atrophy
2017 Alzheimer's Association Research Grant to Promote Diversity (AARG-D) - $149,820 over 3 years
How do genetic variations in a family of proteins that regulate energy affect memory and brain function?

Pathophysiologic Link between TDP-43 Pathology and Alzheimer’s Disease
2017 Alzheimer’s Association Clinical Fellowship (AACF) - $139,059 over 2 years
Does abnormal build-up of the TDP-43 protein in the brain impact the progression of Alzheimer’s disease?

Prion-like tauopathy in post-traumatic Alzheimer’s disease
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How does traumatic brain injury progress to Alzheimer's disease?

9

Diagnosis, Assessment and Disease Monitoring

Memory Deficits in Alzheimer’s Disease: In vivo Frontal Cortical Mechanisms
2017 Alzheimer’s Association Research Fellowship (AARF) - $174,984 over 3 years
Can studying nerve cell activity in the brains of living mice reveal new mechanisms that underlie memory problems in Alzheimer’s
disease?

Examining the trajectory of Subjective Cognitive Decline in preclinical AD
2017 Alzheimer's Association Research Grant (AARG) - $149,913 over 3 years
How might people who notice their own problem with memory be at greater risk for developing Alzheimer’s disease?

Brain Blood Flow in Middle-Aged Adults at Low and High Risk of Alzheimer’s Disease
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
How does brain blood flow in middle-age relate to the risk of developing Alzheimer’s disease?

Non-invasive ocular screening approach to identify early biomarkers in AD.
2017 Alzheimer's Association Research Grant to Promote Diversity (AARG-D) - $120,000 over 2 years
Can a non-invasive eye test be used to detect, diagnose, and monitor early stages of Alzheimer’s disease?

Neurobiology of Hallucinations and Delusions in Alzheimer’s Disease
2017 Alzheimer’s Association Clinical Fellowship (AACF) - $175,000 over 3 years
What are the underlying brain changes associated with increased risk for hallucinations and delusions in people with Alzheimer’s
disease?

Longitudinal Cognitive and Biomarker Trajectories of MCI Subtypes
2017 Alzheimer’s Association Research Grant (AARG) - $149,995 over 3 years
Can improved diagnosis of different types of mild cognitive impairment help predict who is at risk for Alzheimer’s disease?
1
0


NODDI vs. DTI metrics in predicting amyloid and tau pathology
2017 Alzheimer's Association Research Grant (AARG) - $149,999 over 3 years
Can a commonly available diagnostic tool, MRI, replace current imaging methods to detect brain changes in Alzheimer's disease?

Developing advanced blood-brain barrier permeability imaging for early AD
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Can a faster type of magnetic resonance imaging detect subtle changes in the blood-brain barrier associated with cognitive
impairment?

Salivary biomarkers of Alzheimer's disease
2017 Alzheimer's Association Research Grant (AARG) - $149,451 over 3 years
Can biological changes in saliva indicate which people are at risk for Alzheimer's disease?

Cognitive and Biological Changes in APOE4 Carriers: Implications for Alzheimer’s Disease
2017 Alzheimer’s Association Research Grant (AARG) - $149,700 over 3 years
What are the earliest signs of Alzheimer’s disease in middle-aged adults who carry the APOE-e4 genetic variation?

Cerebral Perfusion and Metabolism in Chronic Traumatic Encephalopathy
2017 Alzheimer's Association Research Grant (AARG) - $149,999.77 over 3 years
Can brain imaging distinguish chronic traumatic encephalopathy from other forms of dementia?

Proteomics and Lipidomics to Study Alzheimer’s Disease in African Americans
2017 Alzheimer's Association Research Grant to Promote Diversity (AARG-D) - $150,000 over 3 years
How does the body’s ability to regulate lipids influence the risk of Alzheimer’s disease in people of African ancestry?

Functional and Cognitive Health Assessment of Older Adults with Dementia
1
1

2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Can smart technology in the home be used to assess early functional and behavioral impairment?

Perceived racism as a chronic stressor and cognition in Black Seniors
2017 Alzheimer's Association Research Grant (AARG) - $149,415 over 3 years
How does racial discrimination change brain function and structure in ways that may increase the risk of Alzheimer's disease?

Amyloid PET as a biomarker for white matter integrity in Alzheimer disease
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Could amyloid PET imaging be used to tell us more about possible damage occurring in the brain's white matter associated with
Alzheimer's?

Biopsychosocial contributions to early brain changes in African Americans
2017 Alzheimer's Association Research Grant to Promote Diversity (AARG-D) - $149,881 over 3 years
How does life stress, psychological resilience, and related factors influence the risk for Alzheimer's disease and its rate of
progression in people of African ancestry?

Cognitive Process Scores to Improve Preclinical AD Detection
2017 Alzheimer's Association Research Fellowship (AARF) - $175,000 over 3 years
Can the strategy or "the process" an individual uses on a test be added to measure early cognitive impairment?

1
2

Translational Research and Clinical Interventions

Elucidating the therapeutic potential of Intersectin in Alzheimer's disease
2017 Alzheimer's Association Research Fellowship to Promote Diversity (AARF-D) - $140,000 over 2 years
Can a molecule that helps coordinate multiple cellular processes disrupted in Alzheimer’s be a target for future therapies?

Sex Differences in Exercise Efficacy: Possible Role of BDNF and Stress Axis
2017 Alzheimer’s Association Research Fellowship (AARF) - $175,000 over 3 years
This award was made possible by the Alzheimer's Association and Brain Canada.
Are there sex differences in the benefits of exercise on cognitive function?

Perimenopause in the ApoE4 Brain: Accelerated Myelin Catabolism for Fuel
2017 Sex and Gender in Alzheimer’s (SAGA) - $249,279 over 3 years
Does the loss of estrogen in mid-life promote Alzheimer’s disease in women who have a genetic risk factor for dementia?

Targeting Adult Neurogenesis for Alzheimer’s Disease Therapy
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How might enhancing the brain’s ability to produce new neurons be an effective therapy for Alzheimer’s disease?

Drug Development of a Novel PDE5 Inhibitor for Alzheimer’s Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $175,000 over 3 years
Can a novel compound help preserve nerve cell function and prevent memory loss in Alzheimer’s disease?

A Phase I Single Ascending Dose Safety and Pharmacokinetic Study of NTRX-07
2017 Part the Cloud: Translational Research Funding for Alzheimer’s Disease - $700,000 over 2 years
This Phase I clinical trial will test the safety of NTRX-07, an experimental drug designed to reduce brain inflammation in Alzheimer’s
disease

Phase I Study with NPT088, a Fusion Protein to Treat Alzheimer’s Disease
2017 Part the Cloud: Translational Research Funding for Alzheimer’s Disease - $700,000 over 2 years
13

This Phase I clinical trial will determine if the drug, NPT088, is safe and can reduce abnormal protein clumps that accumulate in the
brain during Alzheimer’s disease

Claims Data Mining to Predict Side Effects of Anti-Dementia Drugs
2017 Alzheimer’s Association Research Grant to Promote Diversity (AARG-D) - $149,386 over 3 year
What factors increase the risk for cardiovascular side effects in people taking medications to treat the symptoms of Alzheimer’s
disease?

Targeting microglial potassium channels Kv1.3 for the treatment of AD
2017 Alzheimer's Association Research Fellowship (AARF) - $139,735 over 2 years
Can the release of inflammatory molecules from microglial cells in the brain be blocked to protect nerve cells from damage?

Effects of psychotropic medications in a mouse model of tauopathy.
2017 Alzheimer's Association Research Fellowship (AARF) - $140,000 over 2 years
Can FDA-approved psychiatric medications reduce behavioral symptoms and brain changes observed in Alzheimer’s disease?

Inhibition of Phospholipase D1 as therapeutic in AD-related memory deficits
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
Does inhibition of the protein phospholipase D1 prevent or slow degeneration of synapses that occurs in Alzheimer’s disease?

Cognitive Behavioral Therapy for African Americans with MCI
2017 Alzheimer's Association Clinician Scientist Fellowship to Promote Diversity (AACSF-D) - $170,000 over 3 years
Can targeted cognitive-behavioral therapy lower Alzheimer’s disease risk in African Americans?

Engaging Diverse Populations in Behavioral Interventions for MCI
2017 Alzheimer’s Association Clinical Fellowship to Promote Diversity (AACF-D) - $174,961 over 3 years
What are the barriers for African Americans to participate in a program to help delay progression to Alzheimer’s disease?

Molecular Underpinnings of Clinical and Neuropathologic Heterogeneity in AD
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
14

Why do the brain changes associated with Alzheimer’s disease differ across individuals?

Stopping Tau Propagation by Receptor-Mediated Synaptic Proteolysis
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
Can activation of proteasomes help stop the movement of abnormal tau protein between nerve cells in Alzheimer’s disease?

Functional and Structural Brain Changes With Testosterone Supplementation
2017 Sex and Gender in Alzheimer’s (SAGA) - $199,714 over 2 years
Is there an “optimal” level of testosterone that can promote healthy brain function and reduce the risk for Alzheimer’s disease in
aging men and women?

Gender Difference in Human and Primate Serotonin Network
2017 Sex and Gender in Alzheimer’s (SAGA) - $249,999 over 3 years
How do sex-based differences in the brain network that regulates the chemical serotonin impact the risk for Alzheimer’s disease?

Strategies to prevent cognitive decline in non-demented subjects
2017 Alzheimer's Association Clinician Scientist Fellowship to Promote Diversity (AACSF-D) - $174,990 over 3 years
Can exercise, brain training and other non-drug therapies help slow the loss of brain health leading to Alzheimer's disease?

Group Therapy for Dementia Caregivers at Risk for Complicated Grief
2017 Alzheimer’s Association Research Grant (AARG) - $149,998 over 3 years
Can a novel group therapy intervention help prevent complicated grief in dementia caregivers?

A Clinical Trial of BDNF Gene Therapy in Alzheimer’s Disease
2017 Part the Cloud: Translational Research Funding for Alzheimer’s Disease - $700,000 over 3 years
This Phase I clinical trial will test the safety of a novel therapy to prevent nerve cell loss in Alzheimer’s disease

Phase 1b MAD Study of a Novel Drug (MW189) Targeting Neuroinflammation
2017 Part the Cloud: Translational Research Funding for Alzheimer’s Disease - $997,738 over 2 years
This Phase I clinical trial will determine the safety of MW189, an experimental drug designed to reduce brain inflammation
15

Epidemiology (Dementia Risk Factors and Prevention)

Biopsychosocial Pathways from Loneliness to Alzheimer’s Disease
2017 Alzheimer’s Association Research Fellowship (AARF) - $175,000 over 3 years
How do social isolation and loneliness affect the risk of developing Alzheimer’s and related dementias?

The impact of motherhood and APOE genotype on the aging brain
2017 Alzheimer's Association Research Fellowship (AARF) - $175,000 over 3 years
Can APOE-e4 status and changes in the brain during pregnancy and motherhood affect a woman’s risk for Alzheimer’s disease?

Estradiol-APOE Interactions in a Mouse Model of Alzheimer’s Disease
2017 Sex and Gender in Alzheimer’s (SAGA) - $250,000 over 3 years
Do variations in the APOE gene impact the effects of estrogen on brain function and the risk for developing Alzheimer’s disease?

Sleep, Cognition, and Inflammation Following Natural or Surgical Menopause
2017 Alzheimer’s Association Research Fellowship (AARF) - $139,458 over 2 years
How does the loss of estrogen affect cognition in a high-risk Alzheimer’s population?

Sex Specific Interactions of Modifiable and Non-modifiable Risk Factors of Alzheimer’s Disease
2017 Sex and Gender in Alzheimer’s (SAGA) - $250,000 over 3 years
Are there sex differences in the way risk factors interact to influence the development of Alzheimer’s disease?

Sex and genetic risk factors in postoperative dementia
2017 Alzheimer's Association Clinician Scientist Fellowship (AACSF) - $174,952 over 3 years
How does a person’s sex and genetic background contribute to cognitive decline after surgery?

Can subtle cognitive decline predict biomarker positivity and incident MCI?
2017 Alzheimer's Association Research Grant (AARG) - $149,998 over 3 years
16

Do people in middle age develop an early form of memory loss that can predict their risk for dementia?

17

Care, Support and Health Economics of Alzheimer’s Disease

Sensor and Simulation-based Fall Injury Mitigation for Senior Citizens
2017 Alzheimer’s Association Research Grant (AARG) - $150,000 over 3 years
Can a novel wearable technology help prevent fall-related injuries in people with Alzheimer’s disease?

STAND UP: Sitting Time, Activity, and Dementia in Underserved Populations
2017 Alzheimer's Association Research Fellowship to Promote Diversity (AARF-D) - $136,915 over 2 years
Can older people from underserved communities benefit from physical activity programs in adult day service settings?

A Neighborhood Approach to Increase Physical Activity and Social Engagement
2017 Alzheimer’s Association Research Grant to Promote Diversity (AARG-D) - $146,784 over 3 years
Can an intervention that combines walking and social engagement improve memory in African-Americans with mild cognitive
impairment?

Racial and Ethnic Disparities in ADRD Diagnosis, Treatment and Costs
2017 Alzheimer's Association Research Grant (AARG) - $150,000 over 3 years
How does a person’s racial or ethnic background influence the diagnosis of Alzheimer’s disease, access to treatment, and costs of
care?

Study of the Psychosocial Effects of Preclinical Alzheimer’s Disease
2017 Alzheimer's Association Research Fellowship (AARF) - $168,625 over 3 years
Does a diagnosis of early-stage Alzheimer's disease change feelings of mental and social well-being?

SASEI [sas-ee]: Sexuality and Neurodegenerative Conditions
2017 Alzheimer’s Association Research Grant to Promote Diversity (AARGD) - $150,000 over 3 years
Can a new tool called SASEI help identify and measure changes in sexual behavior in people with Alzheimer’s and other
dementias?

18


